Recombinant human thyroid stimulating hormone in 2008: focus on thyroid cancer management

Radioiodine (RAI) ablation following thyroidectomy is standard of care treatment for patients with intermediate or high risk differentiated thyroid cancer. Traditionally, this has been achieved by forgoing thyroid hormone replacement postoperatively, allowing endogenous thyroid stimulating hormone (...

Descripción completa

Detalles Bibliográficos
Autores principales: Gramza, Ann, Schuff, Kathryn G
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2009
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2994210/
https://www.ncbi.nlm.nih.gov/pubmed/21127756

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2994210/
https://www.ncbi.nlm.nih.gov/pubmed/21127756

Ejemplares similares